Extendicare (TSE:EXE) Given New C$39.00 Price Target at TD

by · The Cerbat Gem

Extendicare (TSE:EXE – Get Free Report) had its target price boosted by analysts at TD from C$32.00 to C$39.00 in a research report issued on Monday,BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. TD’s target price would suggest a potential upside of 22.18% from the company’s previous close.

Other equities research analysts also recently issued reports about the company. BMO Capital Markets lifted their target price on Extendicare from C$24.00 to C$30.00 in a report on Monday, March 2nd. Canadian Imperial Bank of Commerce lifted their target price on Extendicare from C$22.00 to C$32.00 in a report on Thursday, April 2nd. TD Securities upgraded Extendicare from a “hold” rating to a “buy” rating and lifted their target price for the stock from C$19.00 to C$32.00 in a report on Monday, April 6th. National Bank Financial lifted their target price on Extendicare from C$24.50 to C$29.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Finally, Desjardins set a C$34.50 target price on Extendicare and gave the stock a “buy” rating in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of C$30.44.

View Our Latest Stock Analysis on Extendicare

Extendicare Trading Down 4.5%

EXE stock traded down C$1.52 during mid-day trading on Monday, reaching C$31.92. The company’s stock had a trading volume of 300,655 shares, compared to its average volume of 317,838. The company has a market cap of C$3.02 billion, a price-to-earnings ratio of 28.68 and a beta of 1.27. The business’s 50 day moving average price is C$27.61 and its 200 day moving average price is C$23.41. The company has a current ratio of 1.44, a quick ratio of 0.98 and a debt-to-equity ratio of 82.55. Extendicare has a 12 month low of C$12.12 and a 12 month high of C$35.62.

Extendicare (TSE:EXE – Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported C$0.42 earnings per share for the quarter. The business had revenue of C$465.22 million during the quarter. Extendicare had a return on equity of 45.35% and a net margin of 6.99%. On average, equities research analysts predict that Extendicare will post 0.6134729 EPS for the current year.

About Extendicare

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.

Featured Stories